Literature DB >> 16644085

Abnormal neurological signs, visual contrast sensitivity, and the deficit syndrome of schizophrenia.

Csongor Cimmer1, István Szendi, Gábor Csifcsák, György Szekeres, Zoltán Ambrus Kovács, István Somogyi, György Benedek, Zoltán Janka, Szabolcs Kéri.   

Abstract

This study was designed to investigate the relationship between abnormal neurological signs, visual contrast sensitivity, and the deficit syndrome of schizophrenia. Visual contrast sensitivity for counterphase-modulated low spatial frequency gratings was measured in 32 non-deficit and 12 deficit schizophrenia patients and 20 healthy controls subjects. Abnormal neurological signs were evaluated with the Neurological Evaluation Scale (NES). Compared with the controls, patients with schizophrenia displayed impaired visual contrast sensitivity, which was associated with sensory integration deficits, as measured with the NES. The deficit syndrome was predicted by negative symptoms and sensory integration deficits. These results suggest that early-stage perceptual dysfunctions, which may reflect the abnormality of precortical magnocellular visual pathways, are related to a specific group of abnormal neurological signs.

Entities:  

Mesh:

Year:  2006        PMID: 16644085     DOI: 10.1016/j.pnpbp.2006.03.021

Source DB:  PubMed          Journal:  Prog Neuropsychopharmacol Biol Psychiatry        ISSN: 0278-5846            Impact factor:   5.067


  10 in total

1.  Expression of dopamine D2 and D3 receptors in the human retina revealed by positron emission tomography and targeted mass spectrometry.

Authors:  Fernando Caravaggio; Enzo Scifo; Etienne L Sibille; Sergio E Hernandez-Da Mota; Philip Gerretsen; Gary Remington; Ariel Graff-Guerrero
Journal:  Exp Eye Res       Date:  2018-06-05       Impact factor: 3.467

2.  Cognitive function mediates the relationship between visual contrast sensitivity and functional outcome in schizophrenia.

Authors:  Shaynna N Herrera; Vance Zemon; Nadine Revheim; Gail Silipo; James Gordon; Pamela D Butler
Journal:  J Psychiatr Res       Date:  2021-10-01       Impact factor: 4.791

3.  Psilocybin links binocular rivalry switch rate to attention and subjective arousal levels in humans.

Authors:  Olivia L Carter; Felix Hasler; John D Pettigrew; Guy M Wallis; Guang B Liu; Franz X Vollenweider
Journal:  Psychopharmacology (Berl)       Date:  2007-09-14       Impact factor: 4.530

4.  Curveball: A tool for rapid measurement of contrast sensitivity based on smooth eye movements.

Authors:  Scott W J Mooney; N Jeremy Hill; Melis S Tuzun; Nazia M Alam; Jason B Carmel; Glen T Prusky
Journal:  J Vis       Date:  2018-11-01       Impact factor: 2.240

5.  Deficit schizophrenia: an update.

Authors:  Brian Kirkpatrick; Silvana Galderisi
Journal:  World Psychiatry       Date:  2008-10       Impact factor: 49.548

6.  Measuring contrast sensitivity.

Authors:  Denis G Pelli; Peter Bex
Journal:  Vision Res       Date:  2013-05-03       Impact factor: 1.886

7.  New visual information processing abnormality biomarker for the diagnosis of Schizophrenia.

Authors:  Ivan Koychev; Wael El-Deredy; John Francis William Deakin
Journal:  Expert Opin Med Diagn       Date:  2011-07-01

Review 8.  THE USE OF ELECTRORETINOGRAPHY AND OPTICAL COHERENCE TOMOGRAPHY IN PATIENTS WITH SCHIZOPHRENIA.

Authors:  Din Duraković; Ante Silić; Vjekoslav Peitl; Rašeljka Tadić; Kristina Lončarić; Trpimir Glavina; Daniela Šago; Ljiljana Pačić Turk; Dalibor Karlović
Journal:  Acta Clin Croat       Date:  2020-12       Impact factor: 0.932

9.  Gradiate: A radial sweep approach to measuring detailed contrast sensitivity functions from eye movements.

Authors:  Scott W J Mooney; Nazia M Alam; N Jeremy Hill; Glen T Prusky
Journal:  J Vis       Date:  2020-12-02       Impact factor: 2.240

10.  Selectively reduced contrast sensitivity in high schizotypy.

Authors:  Lauren Harper; Emily Spencer; Colin Davidson; Claire V Hutchinson
Journal:  Exp Brain Res       Date:  2019-11-28       Impact factor: 1.972

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.